Butt, Nauman M <br/><br/>
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.  [electronic resource] 

 -  Leukemia & lymphoma  Sep 2003 
 - 1509-13 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/1042819031000083019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Antigens, CD34--analysis<br/>Cyclophosphamide--administration & dosage<br/>Cyclosporine--therapeutic use<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease--etiology<br/>Hematopoietic Stem Cells--immunology<br/>Humans<br/>Immunomagnetic Separation<br/>Immunophenotyping<br/>Immunosuppressive Agents--therapeutic use<br/>Leucovorin--therapeutic use<br/>Leukemia, Myeloid--therapy<br/>Lymphocyte Depletion--methods<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transplantation Conditioning<br/>Transplantation, Homologous--adverse effects<br/>Whole-Body Irradiation